"Until just now," observed Dr. Tomáš Cihlář, senior scientist at Gilead Sciences, "we could not possibly comprehend that our freedom…could be threatened by something as simple and as banal as a virus."
Americans are paying the highest price in the world for Remdesivir because the Trump administration is allowing Gilead Sciences to jack up the price on this #COVID19 treatment. This needs to change. We need to lower costs and ensure this treatment is accessible to people.
A WHO panel advised doctors against using Gilead Sciences' antiviral drug remdesivir as a treatment for patients hospitalized with COVID-19.
Shares of Gilead Sciences Inc. fell in after-hours trading Thursday after a WHO panel recommended against doctors using the drug remdesivir to treat coronavirus patients.
REVERSALtoUP: $GILD Gilead Sciences, Inc 📈 🔜 TradeIdeas via ⟶
The US Food and Drug Administration has approved remdesivir for the treatment of coronavirus infection, according to the drug's maker, Gilead Sciences
JUST IN: The US Food and Drug Administration has approved remdesivir for the treatment of coronavirus infection, the drug’s maker, Gilead Sciences, says
After weeks of donating the antiviral drug remdesivir to hospitals with severely ill coronavirus patients, the drug’s maker, Gilead Sciences, announced that it has settled on a price: $390 per vial, which works out to be roughly $2,340 per treatment course
A study funded by Gilead Sciences evaluating the use of its drug remdesivir to treat 53 seriously ill COVID-19 patients found that some got better. But there was no control group, so strong conclusions weren't possible.
BREAKING: Gilead Sciences says it's aware of positive data emerging from the study of remdesivir for the treatment of COVID-19, and that the trial has met its primary endpoint